MerLion Pharmaceuticals is VC-Funded and has raised funding across Series C1 and Series C rounds. It is backed by KBB Kapitalbeteiligungsgesellschaft MBH and Aurelia Technologie-Fonds I & Co Beteiligungen KG Frankfurt Am Main Germany.
Alternatives.pe tracks MerLion Pharmaceuticals's funding history, valuation trends, ownership structure, and transaction activity over time.
Last Updated: 2026-07-21
Explore the latest updates and insights
MerLion Pharmaceuticals raised an undisclosed amount via a private placement to European strategic ... see summary
MerLion Pharmaceuticals secures USD7 million in Series C funding from Aravis Ventures, Aurelia ... see summary
A view of the number of employees over time
MerLion Pharmaceuticals secures USD25 million in Series B funding led by Aravis Venture of ... see summary
MerLion Pharmaceuticals secures USD13.5 million in Series A funding led by Aravis, Bioveda, EDB ... see summary
Key members of the management team